Microfluidic Enrichment of Intact Viral Particles by Stoichiometric Balanced DNA Computation

25 October 2023, Version 2
This content is a preprint and has not undergone peer review at the time of posting.


Applications in health diagnostics, community safety and environmental monitoring require selective and quantitatively accurate active viral load assessment. Herein, we report a microfluidic enrichment strategy to separate intact SARS-CoV-2 particles by the AND logic gate with the inputs of cholesterol oligonucleotides for the envelope and aptamers for the spike. Considering the unequal quantity of endogenous spike and lipid membrane on SARS-CoV-2, a dual-domain binding strate-gy based on two aptamers targeting two spike domains was applied to balance the spike-envelope stoichiometric ratio. With the stoichiometric balanced DNA computation and the promoted microscale mass transfer of herringbone chip, the devel-oped strategy enables sensitively detection of pseudotyped SARS-CoV-2 with a limit of detection as low as 34 active virion/μL, but also distinguishes from their inactive counterparts, other nontarget viruses and free spike. Moreover, the captured viral particles can be released through DNase I treatment with up to 90 % efficiency, which is fully compatible with virus culture and sequencing. Overall, the developed strategy not only 100% identifies healthy donors (n = 8) and patients (n = 14) with SARS-CoV-2 infection, but also provides a novel perspective on regulating of stoichiometric ratio to achieve a more biologically appropriate DNA computation.


Stoichiometric balanced DNA computation
Intact SARS-CoV-2 particles
dual-domain aptamers

Supplementary materials

Methods and Supplementary Tables


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.